Ocugen (OCGN) Cash from Financing Activities (2014 - 2026)
Ocugen's Cash from Financing Activities was $80.37 million in Q2 2026, compared with $61,000 a year earlier and up 129.7% from the prior quarter.
Ocugen (OCGN) Cash from Financing Activities (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Ocugen's Cash from Financing Activities was $133.86 million through Jun 30, 2026, up 109.9% year-over-year; for FY2025, it came in at $17.33 million, down 73.3% from FY2024.
- Cash from Financing Activities shows a five-year compound annual growth rate of -11.3% (FY2020 to FY2025).
- In earlier years, Cash from Financing Activities was $64.86 million in FY2024 (+210.6%), $20.88 million in FY2023 (-64.9%), $59.48 million in FY2022 (-50.7%) and $120.68 million in FY2021 (+281.8%).
- The Q2 2026 figure marks the highest quarterly Cash from Financing Activities since Q2 2021.
- The best year-over-year quarter for Cash from Financing Activities over five years was Q3 2022 (growth of 774.5%); the worst was Q4 2025 (a decline of 100.0%).
- Per Business Quant data, OCGN's Cash from Financing Activities in the three quarters before Q2 2026 was $34.98 million (Q1 2026), $2,000 (Q4 2025) and $18.51 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -7.22 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 6.82 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -2.43 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 6.63 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | -4.39 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -1.53 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | -2.51 Bn |
| 10 | Ocugen | 322.34 Mn | 87.56 Mn | - | 161,000.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 161,000.00 |
| Jun 30, 2026 | 80.37 Mn |
| Mar 31, 2026 | 34.98 Mn |
| Dec 31, 2025 | 2,000.00 |
| Sep 30, 2025 | 18.51 Mn |
| Jun 30, 2025 | 61,000.00 |
| Mar 31, 2025 | -1.25 Mn |
| Dec 31, 2024 | 30.17 Mn |
| Sep 30, 2024 | 34.79 Mn |
| Jun 30, 2024 | 45,000.00 |
| Mar 31, 2024 | -145,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Sep 30, 2023 | -35,000.00 |
| Jun 30, 2023 | 15.40 Mn |
| Mar 31, 2023 | 5.50 Mn |
| Dec 31, 2022 | 8.18 Mn |
| Sep 30, 2022 | 962,000.00 |
| Jun 30, 2022 | 236,000.00 |
| Mar 31, 2022 | 50.10 Mn |
| Dec 31, 2021 | 605,000.00 |
Ocugen Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=OCGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "OCGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=OCGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();